Capital Research Global Investors Boosts Boston Scientific Stake

Institutional investor adds 23,940 shares to its position in medical device company

Mar. 11, 2026 at 8:36am

Got story updates? Submit your updates here. ›

Capital Research Global Investors, a major institutional investor, increased its stake in Boston Scientific Corporation (NYSE:BSX) by 0.4% during the third quarter, according to a recent SEC filing. The investor now owns 6,633,733 shares of the medical equipment provider's stock, valued at approximately $647.65 million.

Why it matters

This transaction highlights the continued institutional investor interest in Boston Scientific, a leading medical device company. The stock's performance and growth prospects are closely watched by the investment community.

The details

According to the 13F filing, Capital Research Global Investors acquired an additional 23,940 shares of Boston Scientific during the third quarter, bringing its total position to 6,633,733 shares. This represents approximately 0.45% of the company's outstanding stock. Boston Scientific is a major manufacturer of medical devices used in less-invasive procedures across cardiovascular, digestive, urologic, and other medical fields.

The transaction occurred during the third quarter of the year.

The players